Capitainer Appoints New Chief Financial Officer
Capitainer, a leading Swedish MedTech company specializing in advanced self-sampling solutions, is pleased to announce that Kristina Thomsen Hall has been appointed as its new Chief Financial Officer (CFO).
Kristina Thomsen Hall succeeds Kerstin Widman, who is stepping down after four years to pursue new opportunities.
Kristina Thomsen Hall brings over 10 years of experience in financial management and leadership. She has held key positions as Finance Director at Sea by Maritech and CFO at Chinsay, and has also worked as a consultant and executive for several international companies. Her experience spans budgeting, financial analysis, and capital raising efforts, as well as M&A, due diligence, and corporate restructuring.
As CFO at Capitainer, Kristina will oversee all financial operations, including financial planning, reporting, and budgeting. She will play a key role in shaping the company’s financial strategy to drive continued growth and success.
"We are excited to welcome Kristina Thomsen Hall to our executive team," says Christopher Aulin, CEO. "Her extensive experience and proven track record in financial management make her an ideal fit for Capitainer as we continue to execute our strategic plan and drive long-term value."
Christopher Aulin adds, "I would also like to take this opportunity to thank Kerstin Widman for her leadership and valuable contributions during a period of significant growth for Capitainer. We wish her all the best in her future endeavors."
Commenting on her new role, Kristina Thomsen Hall says, "I am excited to join Capitainer and to work alongside such a talented team. I look forward to building on the strong foundation already in place and supporting the company in achieving its strategic goals."
For more information, please contact:
Christopher Aulin, CEO
Phone: +46 (0)708 977577
Email: christopher.aulin@capitainer.com
About Capitainer
Capitainer AB is a Swedish MedTech company that develops and sells patient-centric solutions for self-sampling of blood, plasma, and urine. Founded in 2016, Capitainer has developed unique technologies for collecting and drying exact volumes of fluid within easy-to-use sampling cards. These cards may be sent as standard post to relevant testing laboratories, thus bypassing the need for cold chain logistics and specialised packaging. Capitainer’s products are market-leading with respect to precision and accuracy, with demonstrated equal performance to established pipetting methods. The products are applicable within several market segments, including but not limited to, clinical biomarkers, therapeutic drug monitoring, genomics, drug abuse and doping testing, and R&D and clinical studies.
Tags:
